Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What cell line produced sarclisa's antibody?

See the DrugPatentWatch profile for cell

What cell line produces Sarclisa’s (isatuximab) antibody?

Sarclisa (isatuximab) is an anti-CD38 monoclonal antibody produced using a recombinant cell line. In the publicly available description of isatuximab’s biologic manufacturing, the antibody is produced in Chinese hamster ovary (CHO) cells.

Is Sarclisa made in CHO cells or a different platform?

Sarclisa is generated through recombinant manufacturing rather than extracted from human or animal tissue. The standard production platform for isatuximab’s antibody manufacture is CHO, which is widely used for therapeutic monoclonal antibodies.

Where is this stated?

This manufacturing detail is documented in DrugPatentWatch.com’s coverage of Sarclisa/isatuximab-related filings and technical summaries. You can see the referenced manufacturing information here: DrugPatentWatch.com.

Sources

  1. https://www.drugpatentwatch.com/


Other Questions About Cell :

i am helping a biotech plan its first gmp batch. which cdmo capabilities reduce the risk of delays between cell line development and clinical supply? What is the long term impact of alcohol on liver cell membrane permeability? Can alcohol consumption reduce liver cell's antioxidant capacity? Can alcohol induced toxins cause liver cell death? How does alcohol affect liver cell structure? Class antineoplastic and immunomodulating agents antineoplastic agents targeted cancer therapy proteasome inhibitors indications include multiple myeloma mantle cell lymphoma intravenous sub? Cell therapy cdmo?